Success Story: NIW Approval for an M.D. Advancing Early Detection Strategies for Chronic Liver Disease
Client’s Testimonial:
"I had a very positive experience working with the team throughout my NIW application process. They were highly professional, responsive, and provided clear guidance at every step. Their expertise made a complex process much more manageable, and I truly appreciate their support. I would confidently recommend their services to others pursuing similar applications.”
On March 18th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Hepatology (Approval Notice).
General Field: Hepatology
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: Turkey
State of Residence at the Time of Filing: Louisiana
Approval Notice Date: March 18th, 2026
Processing Time: 6 months, 2 days (Premium Processing Upgrade Requested)
Case Summary:
The client, an M.D. working in hepatology research, secured an I-140 NIW approval based on a proposed endeavor focused on developing hepatocyte-derived extracellular vesicles as biomarkers for the early detection of chronic liver diseases. The goal of this work is to improve patient treatment outcomes and help halt disease progression before advanced complications emerge. In the petition, we framed this endeavor as one of clear substantial merit and national importance because it addresses a major public health concern and supports earlier, more effective intervention in liver disease management.
To show that the client was well-positioned, we highlighted a record of sustained scholarly activity and peer recognition. The client had authored 49 peer-reviewed journal articles, including 11 first-authored papers, along with 6 conference abstracts and 1 book chapter. These numbers were not presented as sufficient by themselves. Instead, they were used to show a durable pattern of productivity in topics directly tied to hepatology, diagnostics, and liver disease research. The client’s published work had also received 296 citations, which helped demonstrate that other researchers were not merely aware of the work but were relying on it in their own investigations. That kind of independent use is often one of the clearest indicators that contributions are influencing the field beyond the client’s own institution.
We also emphasized that the client had completed at least 32 peer reviews. From an adjudicative perspective, review activity matters because journals invite reviewers based on subject-matter knowledge and professional trust. In other words, this record helped show that the client had earned recognition as someone qualified to evaluate the work of other experts in the field.
The petition also included 2 recommendation letters from experts in the field. These letters supported the client’s technical strengths, the real-world importance of the proposed liver disease research, and the client’s ability to continue advancing the endeavor in the United States. As one expert stated:
“It is therefore clear that [Client] is a leader in the field of hepatology.”
Ultimately, this NIW approval reflected a well-documented case strategy. By combining a nationally important proposed endeavor with a substantial publication record, meaningful citation evidence, and peer review service, we demonstrated that the client’s continued work in hepatology would significantly benefit the United States.